fatty acid

Subretinal Electrical Stimulation Preserves Inner Retinal Function in RCS Rat Retina.

Published May 21, 2013

Subretinal electrical stimulation preserves inner retinal function in RCS rat retina.

Mol Vis. 2013; 19: 995-1005
Ciavatta VT, Mocko JA, Kim MK, Pardue MT

Previously, studies showed that subretinal electrical stimulation (SES) from a microphotodiode array (MPA) preserves electroretinography… Continue reading →

[Laquinimod Is an Oral Drug With a Marked Neuroprotective Effect for Pathogenetic Treatment of Multiple Sclerosis(review)].

Published May 16, 2013

[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].

Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(2 Pt 2): 93-9

New oral therapies of MS cause great attention. This review includes… Continue reading →

Sustained EKR Inhibition by EGFR Targeting Therapies Is a Predictive Factor for Synergistic Cytotoxicity With PDT as Neoadjuvant Therapy.

Published May 15, 2013

Sustained EKR inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.

Biochim Biophys Acta. 2013 Mar; 1830(3): 2659-70
Weyergang A, Selbo PK, Berg K

Tyrosin kinase inhibitors (TKIs) and monoclonal antibodies… Continue reading →

Depression Symptoms After Cancer Treatment Video

Published May 12, 2013

Depression symptoms after cancer treatment video – Symptoms of depression and anxiety are common in cancer survivors. Nurse practitioner Mary Ann Morgan of the H. Lee Moffitt Cancer Center & Research Institut…

How to prevent winter SADness in… Continue reading →

Body Weight Status and Cardiovascular Risk Factors in Adults by Frequency of Candy Consumption.

Published May 3, 2013

Body weight status and cardiovascular risk factors in adults by frequency of candy consumption.

Nutr J. 2013 Apr 30; 12(1): 53
Murphy MM, Barraj LM, Bi X, Stettler N

BACKGROUND: Limited information is available regarding the impact of candy… Continue reading →

A Whole-Grain-Rich Diet Reduces Urinary Excretion of Markers of Protein Catabolism and Gut Microbiota Metabolism in Healthy Men After One Week.

Published April 27, 2013

A Whole-Grain-Rich Diet Reduces Urinary Excretion of Markers of Protein Catabolism and Gut Microbiota Metabolism in Healthy Men after One Week.

J Nutr. 2013 Apr 24;
Ross AB, Pere-Trépat E, Montoliu I, Martin FP, Collino S, Moco S, Godin… Continue reading →

Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System.

Published April 25, 2013

Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System.

PLoS One. 2013; 8(4): e61792
Wang F, Song X, Li X, Xin J, Wang S, Yang W, Wang J, Wu K, Chen… Continue reading →

Biological Rhythms Related to Metabolism in Japanese Shorthorn Cattle Under Varying Environments and Management Techniques.

Published April 24, 2013

Biological rhythms related to metabolism in Japanese Shorthorn cattle under varying environments and management techniques.

Anim Sci J. 2013 Jan 17;
Ogino M, Matsuura A, Yamazaki A, Irimajiri M, Takahashi H, Komatsu T, Kushibiki S, Shingu H, Kasuya E,… Continue reading →

Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Published April 23, 2013

Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

PharmaNutrition. 2013 Apr; 1(2): 41-49
McNamara RK, Strawn JR

Nutrition plays a minor role in psychiatric practice which is currently dominated by a pharmacological treatment algorithm. An accumulating body of… Continue reading →

A Novel Oral Nutraceutical Formula of Omega-3 and Omega-6 Fatty Acids With Vitamins (PLP10) in Relapsing Remitting Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Proof-of-Concept Clinical Trial.

Published April 21, 2013

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

BMJ Open. 2013; 3(4):
Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS

OBJECTIVE:… Continue reading →